111 related articles for article (PubMed ID: 15649435)
1. TRRAP as a hepatic coactivator of LXR and FXR function.
Unno A; Takada I; Takezawa S; Oishi H; Baba A; Shimizu T; Tokita A; Yanagisawa J; Kato S
Biochem Biophys Res Commun; 2005 Feb; 327(3):933-8. PubMed ID: 15649435
[TBL] [Abstract][Full Text] [Related]
2. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
4. An hGCN5/TRRAP histone acetyltransferase complex co-activates BRCA1 transactivation function through histone modification.
Oishi H; Kitagawa H; Wada O; Takezawa S; Tora L; Kouzu-Fujita M; Takada I; Yano T; Yanagisawa J; Kato S
J Biol Chem; 2006 Jan; 281(1):20-6. PubMed ID: 16260778
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140.
Jakobsson T; Osman W; Gustafsson JA; Zilliacus J; Wärnmark A
Biochem J; 2007 Jul; 405(1):31-9. PubMed ID: 17391100
[TBL] [Abstract][Full Text] [Related]
6. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex.
Yanagisawa J; Kitagawa H; Yanagida M; Wada O; Ogawa S; Nakagomi M; Oishi H; Yamamoto Y; Nagasawa H; McMahon SB; Cole MD; Tora L; Takahashi N; Kato S
Mol Cell; 2002 Mar; 9(3):553-62. PubMed ID: 11931763
[TBL] [Abstract][Full Text] [Related]
8. Change in hepatic and plasma bile acid contents and its regulatory gene expression in the chicken embryo.
Sato M; Sato K; Furuse M
Comp Biochem Physiol B Biochem Mol Biol; 2008 Jul; 150(3):344-7. PubMed ID: 18499494
[TBL] [Abstract][Full Text] [Related]
9. Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.
Savkur RS; Thomas JS; Bramlett KS; Gao Y; Michael LF; Burris TP
J Pharmacol Exp Ther; 2005 Jan; 312(1):170-8. PubMed ID: 15329387
[TBL] [Abstract][Full Text] [Related]
10. Dissection of the insulin-sensitizing effect of liver X receptor ligands.
Commerford SR; Vargas L; Dorfman SE; Mitro N; Rocheford EC; Mak PA; Li X; Kennedy P; Mullarkey TL; Saez E
Mol Endocrinol; 2007 Dec; 21(12):3002-12. PubMed ID: 17717069
[TBL] [Abstract][Full Text] [Related]
11. Unliganded thyroid hormone receptor-beta1 represses liver X receptor alpha/oxysterol-dependent transactivation.
Kawai K; Sasaki S; Morita H; Ito T; Suzuki S; Misawa H; Nakamura H
Endocrinology; 2004 Dec; 145(12):5515-24. PubMed ID: 15319359
[TBL] [Abstract][Full Text] [Related]
12. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
Edwards PA; Kast HR; Anisfeld AM
J Lipid Res; 2002 Jan; 43(1):2-12. PubMed ID: 11792716
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Fiévet C; Staels B
Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
[TBL] [Abstract][Full Text] [Related]
14. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.
Handschin C; Meyer UA
Arch Biochem Biophys; 2005 Jan; 433(2):387-96. PubMed ID: 15581595
[TBL] [Abstract][Full Text] [Related]
15. Lipid-activated transcription factors control bile acid glucuronidation.
Barbier O; Trottier J; Kaeding J; Caron P; Verreault M
Mol Cell Biochem; 2009 Jun; 326(1-2):3-8. PubMed ID: 19130183
[TBL] [Abstract][Full Text] [Related]
16. Tissue- and nuclear receptor-specific function of the C-terminal LXXLL motif of coactivator NCoA6/AIB3 in mice.
Li Q; Chu MJ; Xu J
Mol Cell Biol; 2007 Dec; 27(23):8073-86. PubMed ID: 17908797
[TBL] [Abstract][Full Text] [Related]
17. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
Bramlett KS; Yao S; Burris TP
Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
[TBL] [Abstract][Full Text] [Related]
18. Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome.
Nagasaka H; Miida T; Hirano K; Ota A; Murayama K; Yorifuji T; Kobayashi K; Takatani T; Tsukahara H; Hui SP; Takayanagi M; Chiba H
Atherosclerosis; 2008 Jun; 198(2):434-40. PubMed ID: 18430427
[TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor LXR is a glucose sensor.
Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.
Gbaguidi GF; Agellon LB
Nucleic Acids Res; 2004; 32(3):1113-21. PubMed ID: 14960721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
